Ns/lij Hs Huntington Hospital | |
270 Park Avenue, Huntington, New York 11743 | |
(631) 351-2000 | |
Name | Ns/lij Hs Huntington Hospital |
---|---|
Type | Acute Care Hospital |
Location | 270 Park Avenue, Huntington, New York |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 330045 |
NPI Number | 1134395957 |
Organization Name | NORTH SHORE LIJ/HUNTINGTON HOSPITAL |
Doing Business As | HUNTINGTON HOSPITAL |
Address | 270 Park Ave, Huntington, NY 11743 |
Hospital Type | General Acute Care Hospital |
Phone Number | 631-351-2687 |
News Archive
There's good news and there's bad news. Which do you want to hear first? That depends on whether you are the giver or receiver of bad news, and if the news-giver wants the receiver to act on the information, according to researchers at the University of California, Riverside.
ov. Jay Nixon led a three-front charge Tuesday to expand Missouri's Medicaid program, meeting privately with reluctant state senators, rallying publicly with hundreds of disability advocates and chatting with the nation's top health care official about whether particular Medicaid proposals could win federal approval.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Tamsulosin Hydrochloride Capsules USP, 0.4 mg, the generic version of Boehringer Ingelheim's benign prostatic hyperplasia treatment, Flomax.
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
› Verified 1 days ago
NPI Number | 1184175903 |
Organization Name | HUNTINGTON HOSPITAL ASSOCIATION |
Doing Business As | HUNTINGTON HOSPITAL ASSOCIATION PODIATRY |
Address | 270 Park Ave, Huntington, NY 11743 |
Hospital Type | General Acute Care Hospital |
Phone Number | 631-351-2000 |
News Archive
There's good news and there's bad news. Which do you want to hear first? That depends on whether you are the giver or receiver of bad news, and if the news-giver wants the receiver to act on the information, according to researchers at the University of California, Riverside.
ov. Jay Nixon led a three-front charge Tuesday to expand Missouri's Medicaid program, meeting privately with reluctant state senators, rallying publicly with hundreds of disability advocates and chatting with the nation's top health care official about whether particular Medicaid proposals could win federal approval.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Tamsulosin Hydrochloride Capsules USP, 0.4 mg, the generic version of Boehringer Ingelheim's benign prostatic hyperplasia treatment, Flomax.
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
› Verified 1 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
There's good news and there's bad news. Which do you want to hear first? That depends on whether you are the giver or receiver of bad news, and if the news-giver wants the receiver to act on the information, according to researchers at the University of California, Riverside.
ov. Jay Nixon led a three-front charge Tuesday to expand Missouri's Medicaid program, meeting privately with reluctant state senators, rallying publicly with hundreds of disability advocates and chatting with the nation's top health care official about whether particular Medicaid proposals could win federal approval.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Tamsulosin Hydrochloride Capsules USP, 0.4 mg, the generic version of Boehringer Ingelheim's benign prostatic hyperplasia treatment, Flomax.
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
› Verified 1 days ago
Ns/lij Hs Huntington Hospital Acute Care Hospital Location: 270 Park Avenue, Huntington, New York 11743 Phone: (631) 351-2000 |